{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:52:39Z","timestamp":1767048759330,"version":"3.48.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This report details the case of a 77-year-old female with\n                    <jats:italic>Mycobacterium intracellulare<\/jats:italic>\n                    pulmonary disease and history of bladder tumor surgery. The patient initially presented to our hospital with a one-day history of fever. After receiving antibiotic and anti-nontuberculous mycobacterial therapy for three days, the patient remained febrile. The patient\u2019s white blood cell and neutrophil counts were within normal range, while the lymphocyte count was decreased. Chest computed tomography (CT) revealed diffuse ground-glass opacities in the lungs. Further investigations demonstrated a significantly reduced CD4\u2009+\u2009T-lymphocyte count.\n                    <jats:italic>Mycobacterium intracellulare<\/jats:italic>\n                    and\n                    <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                    (PJ) were identified in the bronchoalveolar lavage fluid (BALF) specimen. The patient was treated with oral trimethoprim-sulfamethoxazole (TMP-SMZ) and intravenous caspofungin. Following treatment, the patient\u2019s symptoms improved, and she was discharged. This study reports the first documented case of rare\n                    <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                    pneumonia (PJP) complicating nontuberculous mycobacterial lung disease. It underscores the importance of monitoring immune function and facilitating the early recognition of secondary infections in such patients.\n                  <\/jats:p>","DOI":"10.1186\/s12879-025-12165-x","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T13:05:16Z","timestamp":1763989516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pneumocystis jirovecii pneumonia in a patient with Mycobacterium intracellulare pulmonary disease: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaoni","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"12165_CR1","doi-asserted-by":"crossref","unstructured":"Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline[J]. Eur Respir J. 2020;56(1).","DOI":"10.1183\/13993003.00535-2020"},{"issue":"1","key":"12165_CR2","first-page":"e242","volume":"4","author":"CS Haworth","year":"2017","unstructured":"Haworth CS, Banks J, Capstick T, et al. British thoracic society guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)[J]. BMJ Open Respir Res. 2017;4(1):e242.","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"12165_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40249-021-00844-1","volume":"10","author":"C Liu","year":"2021","unstructured":"Liu C, Song Y, He W, et al. Nontuberculous mycobacteria in china: incidence and antimicrobial resistance spectrum from a nationwide survey[J]. Infect Dis Poverty. 2021;10(1):59.","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"12165_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pulmoe.2018.12.003","volume":"25","author":"A Santos-Silva","year":"2019","unstructured":"Santos-Silva A, Pereira F, Gaio R, et al. Differential risk factors for slowly and rapidly-growing nontuberculous mycobacteria: a retrospective cross-sectional study[J]. Pulmonology. 2019;25(2):114\u20136.","journal-title":"Pulmonology"},{"issue":"11","key":"12165_CR5","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.202212-2195IM","volume":"208","author":"A Nathani","year":"2023","unstructured":"Nathani A, Tauquir A, Khan S, et al. Unusual presentation of Pneumocystis jirovecii pneumonia in an immunocompromised Host[J]. Am J Respir Crit Care Med. 2023;208(11):e44\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"12165_CR6","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1093\/jac\/dkw158","volume":"71","author":"G Maschmeyer","year":"2016","unstructured":"Maschmeyer G, Helweg-Larsen J, Pagano L, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients[J]. J Antimicrob Chemother. 2016;71(9):2405\u201313.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"12165_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13613-020-00649-9","volume":"10","author":"L Ding","year":"2020","unstructured":"Ding L, Huang H, Wang H, et al. Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies[J]. Ann Intensive Care. 2020;10(1):34.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"12165_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.chest.2024.03.024","volume":"166","author":"K Hyung","year":"2024","unstructured":"Hyung K, Kim S, Kim J, et al. Rates and risk factors of progression in patients with nontuberculous mycobacterial pulmonary disease: secondary analysis of a prospective cohort Study[J]. Chest. 2024;166(3):452\u201360.","journal-title":"Chest"},{"issue":"7","key":"12165_CR9","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3201\/eid2007.131801","volume":"20","author":"X Wang","year":"2014","unstructured":"Wang X, Li H, Jiang G, et al. Prevalence and drug resistance of nontuberculous mycobacteria, Northern China, 2008\u20132011[J]. Emerg Infect Dis. 2014;20(7):1252\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"12165_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/cid\/ciad108","volume":"77","author":"J Kim","year":"2023","unstructured":"Kim J, Choi Y, Park J, et al. Impact of treatment on Long-Term survival of patients with Mycobacterium avium complex pulmonary Disease[J]. Clin Infect Dis. 2023;77(1):120\u20136.","journal-title":"Clin Infect Dis"},{"key":"12165_CR11","doi-asserted-by":"crossref","unstructured":"Lombardi A, Villa S, Castelli V, et al. T-Cell exhaustion in Mycobacterium tuberculosis and nontuberculous mycobacteria infection: pathophysiology and therapeutic Perspectives[J]. Microorganisms. 2021;9(12).","DOI":"10.3390\/microorganisms9122460"},{"key":"12165_CR12","doi-asserted-by":"crossref","unstructured":"Apostolopoulou A, Fishman JA. The pathogenesis and diagnosis of Pneumocystis jiroveci Pneumonia[J]. J Fungi (Basel). 2022;8(11).","DOI":"10.3390\/jof8111167"},{"issue":"11","key":"12165_CR13","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s10096-021-04227-0","volume":"40","author":"L Yang","year":"2021","unstructured":"Yang L, Xia P, Zhou Y, et al. Characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with idiopathic membranous nephropathy[J]. Eur J Clin Microbiol Infect Dis. 2021;40(11):2305\u201314.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"12165_CR14","doi-asserted-by":"publisher","first-page":"652383","DOI":"10.3389\/fimmu.2021.652383","volume":"12","author":"G Tang","year":"2021","unstructured":"Tang G, Tong S, Yuan X, et al. Using routine laboratory markers and immunological indicators for predicting Pneumocystis Jiroveci pneumonia in immunocompromised Patients[J]. Front Immunol. 2021;12:652383.","journal-title":"Front Immunol"},{"key":"12165_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijid.2019.08.015","volume":"88","author":"F Jin","year":"2019","unstructured":"Jin F, Liu X, Chen W, et al. High initial (1, 3) Beta-d-Glucan concentration May be a predictor of satisfactory response of c Aspofungin combined with TMP\/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia[J]. Int J Infect Dis. 2019;88:141\u20138.","journal-title":"Int J Infect Dis"},{"key":"12165_CR16","doi-asserted-by":"crossref","unstructured":"Han SA, Ko Y, Shin SJ, et al. Characteristics of circulating CD4(+) T cell subsets in patients with Mycobacterium avium complex pulmonary disease[J]. J Clin Med. 2020;9(5).","DOI":"10.3390\/jcm9051331"},{"key":"12165_CR17","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","volume":"9","author":"A Saeidi","year":"2018","unstructured":"Saeidi A, Zandi K, Cheok YY, et al. T-Cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune Responses[J]. Front Immunol. 2018;9:2569.","journal-title":"Front Immunol"},{"key":"12165_CR18","doi-asserted-by":"publisher","first-page":"931876","DOI":"10.3389\/fimmu.2022.931876","volume":"13","author":"H Park","year":"2022","unstructured":"Park H, Lee W, Choi S, et al. Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection[J]. Front Immunol. 2022;13:931876.","journal-title":"Front Immunol"},{"issue":"2","key":"12165_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1165\/rcmb.2019-0241TR","volume":"63","author":"Z Prasla","year":"2020","unstructured":"Prasla Z, Sutliff RL, Sadikot RT. Macrophage signaling pathways in pulmonary nontuberculous mycobacteria Infections[J]. Am J Respir Cell Mol Biol. 2020;63(2):144\u201351.","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12165-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12165-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12165-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:48:46Z","timestamp":1767048526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12165-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12165"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12165-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1802"}}